Published 1 day ago • loading... • Updated 1 day ago

BSX Deadline: BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit

Rosen Law Firm announced a May 4, 2026, deadline for investors to serve as lead plaintiff in a class action lawsuit against Boston Scientific Corporation involving stock purchased between July 23, 2025, and February 3, 2026.
According to the lawsuit, Boston Scientific allegedly disseminated misleading statements regarding its Electrophysiology segment while concealing that the segment's growth rate was unsustainable and approaching an earlier tipping point than the market anticipated.
When true details entered the market, investors and analysts were "left surprised by Boston Scientific" following the company's net income miss and underwhelming guidance for the first half of fiscal 2026.
Shareholders who purchased Boston Scientific common stock during the Class Period can participate without out-of-pocket fees, with Phillip Kim, Esq. managing inquiries at toll-free 767-3653 or case@rosenlegal.com.
The Rosen Law Firm, ranked among the top 4 firms for securities class actions since 2013, has recovered over $438 million for investors, including a record settlement against a Chinese Company.

Insights by Ground AI